Cited by 403Drug-Induced Hepatotoxicity and ProtectionPharmacogenetics and Drug MetabolismPharmacovigilance and Adverse Drug Reactions

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity

Boelsterli, U·2003·Toxicology and Applied Pharmacology

DOI 10.1016/s0041-008x(03)00368-5

Open this paper in CoChat — free account

Abstract

The nonsteroidal antiinflammatory drug diclofenac causes rare but significant cases of serious hepatotoxicity, typically with a delayed onset (>1-3 months). Because there is no simple dose relationship and because liver injury cannot be reproduced in current animal models, individual patient-specific susceptibility factors have been evoked to account for the increased risk. While these patient factors have remained undefined, a number of molecular hazards have been characterized. Among these are metabolic factors (bioactivation by hCYP2C9 or hCYP3A4 to thiol-reactive quinone imines, activation by hUGT2B7 to protein-reactive acyl glucuronides and iso-glucuronides, and 4'-hydroxylation secondary to diclofenac glucuronidation), as well as kinetic factors (Mrp2-mediated concentrative transport of diclofenac metabolites into bile). From the toxicodynamic view, both oxidative stress (caused by putative diclofenac cation radicals or nitroxide and quinone imine-related redox cycling) and mitochondrial injury (protonophoretic activity and opening of the permeability transition pore) alone or in combination have been implicated in diclofenac toxicity. In some cases, immune-mediated liver injury is involved, inferred from inadvertent rechallenge data and from a number of experiments demonstrating T cell sensitization. Why certain underlying diseases (e.g., osteoarthritis) also increase the susceptibility to diclofenac hepatotoxicity is not clear. To date, cumulative damage to mitochondrial targets seems a plausible putative mechanism to explain the delayed onset of liver failure, perhaps even superimposed on an underlying silent mitochondrial abnormality. Increased efforts to identify both patient-specific risk factors and disease-related factors will help to define patient subsets at risk as well as increase the predictability of unexpected hepatotoxicity in drug development.

Integrity signals

Registry

Crossref · 10.1016/s0041-008x(03)00368-5

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

ACETAMINOPHEN-INDUCED HEPATOTOXICITY
James, L. P., Mayeux, P. R., & Hinson, J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.12.1499 · Cited by 1,033
Incidence of drug-induced hepatic injuries: A French population-based study
Sgro, C., Clinard, F., Ouazir, K., Chanay, H., Allard, C., Guilleminet, C., Lenoir, C., Lemoine, A., & Hillon, P. (2002) · Hepatology · doi:10.1053/jhep.2002.34857 · Cited by 716
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
Modulation of the Mitochondrial Permeability Transition Pore by Pyridine Nucleotides and Dithiol Oxidation at Two Separate Sites
Costantini, P., Chernyak, B. V., Petronilli, V., & Bernardi, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6746 · Cited by 516
Acyl Glucuronides Revisited: Is the Glucuronidation Proces a Toxification as Well as a Detoxification Mechanism?
Spahn-Langguth, H., & Benet, L. Z. (1992) · Drug Metabolism Reviews · doi:10.3109/03602539208996289 · Cited by 407
Clustering of Hepatotoxins Based on Mechanism of Toxicity Using Gene Expression Profiles
Waring, J. F., Jolly, R. A., Ciurlionis, R., Lum, P. Y., Præstgaard, J., Morfitt, D. C., Buratto, B., Roberts, C., Schadt, E. E., & Ulrich, R. G. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9243 · Cited by 376
New Concepts in Immunology Relevant to Idiosyncratic Drug Reactions: The “Danger Hypothesis” and Innate Immune System
Uetrecht, J. (1999) · Chemical Research in Toxicology · doi:10.1021/tx980249i · Cited by 307
Properties of Acyl Glucuronides: Implications for Studies of the Pharmacokinetics and Metabolism of Acidic Drugs
Faed, E. M. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409033562 · Cited by 299
Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions
Banks, A. T., Zimmerman, H. J., Ishak, K. G., & Harter, J. G. (1995) · Hepatology · doi:10.1002/hep.1840220320 · Cited by 296
Drug-Induced Liver Disorders
Kaplowitz, N. (2001) · Drug Safety · doi:10.2165/00002018-200124070-00001 · Cited by 261

Show all 101 references

Sorted by citations

Items 201–300 of 403

The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury
Selvaraj, S., Oh, J., Spanel, R., Länger, F. P., Han, H., Lee, E. H., Yoon, S., & Borlak, J. T. (2017) · Oncotarget · doi:10.18632/oncotarget.21201 · Cited by 21
The collapse of vulture populations in South Asia
Watson, R. T., Gilbert, M., Oaks, J. L., & Virani, M. Z. (2004) · Biodiversity · doi:10.1080/14888386.2004.9712733 · Cited by 20
Pharmacogenomic Biomarkers for Personalized Medicine
Chen, J. J., Lin, W., & Chen, H.-C. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.75 · Cited by 20
Energy metabolism and biotransformation as endpoints to pre-screen hepatotoxicity using a liver spheroid model
Xu, J., & Purcell, W. M. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.05.015 · Cited by 19
Occurrence, toxicity, ecological risk, and remediation of diclofenac in surface water environments: a review with a focus on China
An, X., Tao, Y., Wu, J., Li, Z., Li, H., Chen, S., & Pang, Y. (2025) · Environmental Toxicology and Chemistry · doi:10.1093/etojnl/vgaf005 · Cited by 19
A rapid and specific derivatization procedure to identify acyl‐glucuronides by mass spectrometry
Vaz, A. D. N., Wang, W. W., Bessire, A. J., Sharma, R., & Hagen, A. E. (2010) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.4621 · Cited by 19
The neuroprotective effect of melatonin on the hippocampus exposed to diclofenac sodium during the prenatal period
Yurt, K. K., Kaplan, S., & Kıvrak, E. G. (2017) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2017.05.006 · Cited by 19
Intestinal Metabolism of Diclofenac by Polymorphic UGT2B17 Correlates with its Highly Variable Pharmacokinetics and Safety across Populations
Ahire, D. S., Heyward, S. A., & Prasad, B. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2907 · Cited by 19
Multiple Factors Govern the Association between Pharmacology and Toxicity in a Class of Drugs: Toward a Unification of Class Effect Terminology
Smith, D. A., Harrison, A. C., & Morgan, P. (2011) · Chemical Research in Toxicology · doi:10.1021/tx100408v · Cited by 18
Phytoremediation as a Tool to Remove Drivers of Antimicrobial Resistance in the Aquatic Environment
Chowdhury, K. F., Hall, R. J., McNally, A., & Carter, L. (2023) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/s44169-023-00039-9 · Cited by 20
Liver protecting effects and molecular mechanisms of icariin and its metabolites
Ma, Y., Zhao, C., Hu, H., & Yin, S. (2023) · Phytochemistry · doi:10.1016/j.phytochem.2023.113841 · Cited by 17
Evaluation of drug-induced injury and human response in precision-cut tissue slices
Vickers, A. E. M., & Fisher, R. L. (2012) · Xenobiotica · doi:10.3109/00498254.2012.732714 · Cited by 18
Metabolism and Disposition of 14C-Labeled Peliglitazar in Humans
Wang, L., Munsick, C., Chen, S., Bonacorsi, S. J., Cheng, P. T. W., Humphreys, W. G., & Zhang, D. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035089 · Cited by 18
SideEffectPTM
Wang, S., Li, Y., Ferguson, D. C., & Zhai, C. (2014) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/2649387.2649398 · Cited by 17
Acyl Glucuronide and Coenzyme A Thioester Metabolites of Carboxylic Acid-Containing Drug Molecules: Layering Chemistry with Reactive Metabolism and Toxicology
Mitra, K. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00188 · Cited by 17
Vernonia amygdalina (Del) as an antioxidant, aspirin toxicity, and oxidative stress
Alabi, Q. K., & Adeyemi, W. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819092-0.00048-0 · Cited by 18
Hepatotoxicidad secundaria a fármacos de uso común
García‐Cortés, M., Andrade, R. J., Lucena, M. I., González‐Grande, R., Camargo, R., Bonilla, E. M. F., Martos, J. V., & Alcántara, R. (2005) · Gastroenterología y Hepatología · doi:10.1157/13079002 · Cited by 19
Elucidation of the Mechanisms through Which the Reactive Metabolite Diclofenac Acyl Glucuronide Can Mediate Toxicity
Scialis, R. J., & Manautou, J. E. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.230755 · Cited by 17
A liquid chromatography/tandem mass spectrometry method for detecting UGT‐mediated bioactivation of drugs as their N ‐acetylcysteine adducts in human liver microsomes
Harada, H., Endo, T., Momose, Y., & Kusama, H. (2009) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3912 · Cited by 17
Development of an Oral Exposure Mouse Model to Predict Drug-Induced Hypersensitivity Reactions by Using Reporter Antigens
Nierkens, S. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfi021 · Cited by 17
Hybrid non-animal modeling: A mechanistic approach to predict chemical hepatotoxicity
Chung, E., Wen, X., Jia, X., Ciallella, H. L., Aleksunes, L. M., & Zhu, H. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134297 · Cited by 15
Combined use of surfactant-induced coagulation of poly(allylamine hydrochloride) with peroxidase-mediated degradation for the rapid removal of estrogens and phenolic compounds from water
Saitoh, T., Fukushima, K., & Miwa, A. (2014) · Separation and Purification Technology · doi:10.1016/j.seppur.2014.02.038 · Cited by 16
The Biotransformation and Pharmacokinetics of 14C-Nimesulide in Humans Following a Single Dose Oral Administration
Macpherson, D. (2012) · Journal of Drug Metabolism & Toxicology · doi:10.4172/2157-7609.1000140 · Cited by 16
Application of the comparison approach to open TG-GATEs: A useful toxicogenomics tool for detecting modes of action in chemical risk assessment
Heusinkveld, H. J., Wackers, P. F. K., Schoonen, W. G. E. J., van der Ven, L., Pennings, J. L. A., & Luijten, M. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.08.007 · Cited by 16
Covalent Binding of Phenylacetic Acid to Protein in Incubations with Freshly Isolated Rat Hepatocytes
Grillo, M. P., & Lohr, M. T. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.026153 · Cited by 16
Nutrient environment improves drug metabolic activity in human iPSC-derived hepatocytes and HepG2
Pozo Garcia, V., Çobanoğlu, T. S., Hammer, H. S., Carlota, R., Holm, K., Verfaillie, C., Poetz, O., Jennings, P., & Moco, S. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04139-4 · Cited by 15
Hepatotoxicity assay using human hepatocytes trapped in microholes of a microfluidic device
Yeon, J. H., Na, D., & Park, J. (2010) · Electrophoresis · doi:10.1002/elps.201000122 · Cited by 15
MicroRNA-877-5p is involved in the trovafloxacin-induced liver injury
Mitsugi, R., Itoh, T., & Fujiwara, R. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.10.002 · Cited by 15
Pre-Clinical Assessment of the Potential Intrinsic Hepatotoxicity of Candidate Drugs
van Tonder, J. J., Steenkamp, V., & Gulumi, M. (2013) · InTech eBooks · doi:10.5772/54792 · Cited by 15
Potential protective effect of sunitinib after administration of diclofenac: biochemical and histopathological drug–drug interaction assessment in a mouse model
Tan, J. R., Chakravarthi, S., Judson, J. P., Haleagrahara, N., & Segarra, I. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0861-4 · Cited by 15
Proteomic profiling in incubation medium of mouse, rat and human precision‐cut liver slices for biomarker detection regarding acute drug‐induced liver injury
van Swelm, R. P. L., Hadi, M., Laarakkers, C. M., Masereeuw, R., Groothuis, G. M. M., & Rüssel, F. G. M. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2917 · Cited by 14
Elevated cAMP Protects against Diclofenac-Induced Toxicity in Primary Rat Hepatocytes: A Protective Effect Mediated by the Exchange Protein Directly Activated by cAMP/cAMP-Regulated Guanine Nucleotide Exchange Factors
Mora, F. A. A., Musheshe, N., Oun, A., Buist‐Homan, M., Lezoualc’h, F., Cheng, X., Schmidt, M., & Moshage, H. J. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.120.000217 · Cited by 14
Photocatalysis combined with chromatographic methods as a new promising tool in drug metabolism studies – a review
Gawlik, M., Skibiński, R., Trawiński, J., & Komsta, Ł. (2017) · Acta Chromatographica · doi:10.1556/1326.2016.00202 · Cited by 13
Effects of dissolved organic matter, feeding, and water flow on the bioconcentration of diclofenac in crucian carp (Carassius auratus)
Lu, G., Xie, Z., & Zhang, Z. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-1081-0 · Cited by 14
Drug-Induced Liver Injury in Clinical Trials: As Rare as Hens’ Teeth
Davern, T. J., & Chalasani, N. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.76 · Cited by 14
Nonsteroidal Antiinflammatory Drugs and Leukotriene Receptor Antagonists
Lewis, J. H., & Stine, J. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00022-4 · Cited by 14
Drug‐Induced Liver Disease
Chitturi, S., & Farrell, G. C. (2011) · Wiley eBooks · doi:10.1002/9781119950509.ch27 · Cited by 14
Embryonic exposure to diclofenac disturbs actin organization and leads to myofibril misalignment
Chen, Y., Chang, C., Wang, Y., Wen, C., Chen, Y., Hu, S., Yü, D., & Chen, Y. (2011) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20292 · Cited by 13
Toxins mechanism in instigating hepatotoxicity
Nithiyanandam, S., & Prince, S. E. (2020) · Toxin Reviews · doi:10.1080/15569543.2020.1818105 · Cited by 13
Toxicological Evaluation of Novel Cyclohexenone Derivative in an Animal Model through Histopathological and Biochemical Techniques
Kamil, M. R., Fatima, A., Ullah, S., Ali, G., Khan, R., Ismail, N., Qayum, M., Irimie, M., Dinu, C. G., Ahmedah, H. T., et al. (2021) · Toxics · doi:10.3390/toxics9060119 · Cited by 13
Univariate or multivariate approaches for histopathological biomarkers in the context of environmental quality assessments?
Gusso‐Choueri, P. K., Choueri, R. B., de Araújo, G. S., Cruz, A. C. F., Stremel, T. R. D. O., de Campos, S. X., Abessa, D. M. D. S., & Ribeiro, C. A. D. O. (2022) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2022.113828 · Cited by 15
The pharmacokinetics and metabolism of diclofenac in chimeric humanized and murinized FRG mice
Wilson, C. E., Dickie, A. P., Schreiter, K., Wehr, R., Wilson, E. M., Bial, J., Scheer, N., Wilson, I. D., & Riley, R. J. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2212-1 · Cited by 13
Pharmacology and clinical applications of flupirtine: Current and future options
Lawson, K. (2019) · World Journal of Pharmacology · doi:10.5497/wjp.v8.i1.1 · Cited by 13
Drug Metabolism: Significance and Challenges
Prakash, C., & Vaz, A. D. N. (2008) · Wiley eBooks · doi:10.1002/9780470409107.ch1 · Cited by 13
Software‐aided cytochrome P450 reaction phenotyping and kinetic analysis in early drug discovery
Cece, E. N., Fontaine, F., Plasencia, G., Teppner, M., Brink, A., Pähler, A., & Zamora, I. (2015) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.7429 · Cited by 12
Assessing Covalent Binding of Reactive Drug Metabolites by Complete Protein Digestion and LC–MS Analysis
Mitrea, N., LeBlanc, A. R., St‐Onge, M., & Sleno, L. (2010) · Bioanalysis · doi:10.4155/bio.10.74 · Cited by 12
Urinary proteomic profiling reveals diclofenac-induced renal injury and hepatic regeneration in mice
van Swelm, R. P. L., Laarakkers, C. M., Pertijs, J. C. L. M., Verweij, V. G. M., Masereeuw, R., & Rüssel, F. G. M. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.03.005 · Cited by 12
Quantitative Evaluation of Reactivity and Toxicity of Acyl Glucuronides by [35S]Cysteine Trapping
Harada, H., Toyoda, Y., Abe, Y., Endo, T., & Takeda, H. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00111 · Cited by 12
Development of Novel Diclofenac Analogs Designed to Avoid Metabolic Activation and Hepatocyte Toxicity
Tateishi, Y., Ohe, T., Ogawa, M., Takahashi, K., Nakamura, S., & Mashino, T. (2020) · ACS Omega · doi:10.1021/acsomega.0c04942 · Cited by 12
Gauging Reactive Metabolites in Drug-Induced Toxicity
Eno, M. R., & Cameron, M. D. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140826113520 · Cited by 12
Idiosyncratic Drug-Induced Liver Injury: Mechanisms and Susceptibility Factors
Stephens, C., Lucena, M. I., & Andrade, R. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64089-8 · Cited by 11
Selective voting in convex-hull ensembles improves classification accuracy
Kodell, R. L., Zhang, C., Siegel, E. R., & Nagarajan, R. (2011) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2011.10.003 · Cited by 11
CCR2 and CCR5 promote diclofenac-induced hepatotoxicity in mice
He, Z., Wei, G., Li, N., Niu, M., Gong, S., Wu, G., Wang, T., Jiang, Y., & Chen, P. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1576-3 · Cited by 11
Biocomponents from Opuntia robusta and Opuntia streptacantha fruits protect against diclofenac-induced acute liver damage in vivo and in vitro
Villa-Jaimes, G. S., Mora, F. A. A., González-Ponce, H. A., Avelar-González, F. J., Martínez-Saldaña, M. C., Buist‐Homan, M., & Moshage, H. J. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.104960 · Cited by 12
ADME Principles in Small Molecule Drug Discovery and Development: An Industrial Perspective
Cannady, E. A., Katyayan, K., & Patel, N. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821044-4.00003-0 · Cited by 10
Porcine hepatocytes culture on biofunctionalized 3D inverted colloidal crystal scaffolds as an in vitro model for predicting drug hepatotoxicity
Wu, L., Ferracci, G., Wang, Y., Fan, T. F., Cho, N., & Chow, P. K. H. (2019) · RSC Advances · doi:10.1039/c9ra03225h · Cited by 10
FORMATION AND PROTEIN BINDING OF THE ACYL GLUCURONIDE OF A LEUKOTRIENE B4 ANTAGONIST (SB-209247): RELATION TO SPECIES DIFFERENCES IN HEPATOTOXICITY
Kenny, J. R., Maggs, J. L., Tettey, J. N. A., Harrell, A. W., Parker, S. G., Clarke, S. E., & Park, B. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001677 · Cited by 10
As a painkiller: a review of pre- and postnatal non-steroidal anti-inflammatory drug exposure effects on the nervous systems
Yurt, K. K., & Kaplan, S. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0434-0 · Cited by 10
Toxicity assessment of Diclofenac and its biodegradation metabolites toward mice
Aissaoui, S., Sifour, M., Ouled-Haddar, H., Benguedouar, L., & Lahouel, M. (2017) · Toxicology and Environmental Health Sciences · doi:10.1007/s13530-017-0333-1 · Cited by 10
CHEMOINFORMATICS AND BEYOND
Hasselgren, C., Muthas, D., Ahlberg, E., Andersson, S., Carlsson, L., Noeske, T., Stålring, J., & Boyer, S. K. (2013) · Wiley eBooks · doi:10.1002/9781118742785.ch12 · Cited by 10
Decellularized liver scaffolds for constructing drug-metabolically functional ex vivo human liver models
Liu, J., Hanson, A., Yin, W., Wu, Q., Wauthier, E., Diao, J., Dinh, T., Macdonald, J., Li, R., Terajima, M., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.09.029 · Cited by 9
“Genetic polymorphisms, drug overdosage, or interactions with other medications can lead to variations in the activity of these enzymes, thereby influencing the metabolic rate of diclofenac and the generation of toxic intermediates, ultimately increasing the risk of liver toxicity [28,29].”
Background
Integrating a Microphysiological System and Physiologically Based Pharmacokinetic Modeling to Predict Human Responses to Diclofenac
Choi, S., Lee, J.-H., Kim, O., Jung, Y., Ryu, T., Kim, S. J., Kim, E. J., Sung, J. H., Cha, H. J., & Han, S. (2025) · BioChip Journal · doi:10.1007/s13206-025-00207-0 · Cited by 10
Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury—A Repeated Dose Study in Minipigs for 28 Days
Selvaraj, S., Oh, J., Yoon, S., & Borlak, J. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021445 · Cited by 9
CYP isoform specificity toward drug metabolism: analysis using common feature hypothesis
Ramesh, M., & Bharatam, P. V. (2011) · Journal of Molecular Modeling · doi:10.1007/s00894-011-1105-5 · Cited by 9
Identification and Categorization of Liver Toxicity Markers Induced by a Related Pair of Drugs
Chang, C., Beland, F. A., Hines, W. M., Fuscoe, J. C., Han, T., & Chen, J. J. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12074609 · Cited by 9
Idiosyncratic Drug-Induced Liver Injury: Mechanisms and Susceptibility Factors
Boelsterli, U. A., & Kashimshetty, R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01015-0 · Cited by 9
Self-citation
N-acetylcysteine potentiates diclofenac toxicity inSaccharomyces cerevisiae: stronger potentiation in ABC transporter mutant strains
Al‐Attrache, H., Chamieh, H., Hamzé, M., Morel, I., Taha, S., & Abdel‐Razzak, Z. (2017) · Drug and Chemical Toxicology · doi:10.1080/01480545.2017.1320404 · Cited by 9
Drug-Induced Liver Disease
Roberts, E. A. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547409.022 · Cited by 9
Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in rats
Cooper, D. L., Wood, R. C., Wyatt, J. E., & Harirforoosh, S. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.12.002 · Cited by 9
Measuring Interference of Drug-Like Molecules with the Respiratory Chain: Toward the Early Identification of Mitochondrial Uncouplers in Lead Finding
Stock, U., Matter, H., Diekert, K., Dörner, W., Dröse, S., & Licher, T. (2013) · Assay and Drug Development Technologies · doi:10.1089/adt.2012.463 · Cited by 9
Metformin protects against diclofenac-induced toxicity in primary rat hepatocytes by preserving mitochondrial integrity via a pathway involving EPAC
Mora, F. A. A., Musheshe, N., Arroyave-Ospina, J. C., Geng, Y., Soto, J. M., Rodrigo, J. A., Alieva, T., Buist‐Homan, M., Lezoualc’h, F., Cheng, X., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112072 · Cited by 9
Diclofenac-Induced Cytotoxicity in Direct and Indirect Co-Culture of HepG2 Cells with Differentiated THP-1 Cells
Kawase, A., Takashima, O., Tanaka, S., Shimada, H., & Iwaki, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158660 · Cited by 8
Oral Exposure to Drugs with Immune-Adjuvant Potential Induces Hypersensitivity Responses to the Reporter Antigen TNP-OVA
Kwast, L. M., Fiechter, D., Hassing, I., Bleumink, R., Boon, L., Ludwig, I. S., & Pieters, R. H. H. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr052 · Cited by 8
Sunitinib DDI with paracetamol, diclofenac, mefenamic acid and ibuprofen shows sex-divergent effects on the tissue uptake and distribution pattern of sunitinib in mice
Tan, S. Y., Wong, M. M., Tiew, A. L. W., Choo, Y. W., Lim, S. H., Ooi, I. H., Modamio, P., Fernández, C., Mariño, E. L., & Segarra, I. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3120-9 · Cited by 8
Metabolism of the aquatic pollutant diclofenac in the Lymnaea stagnalis freshwater gastropod
Bouly, L., Fenet, H., Carayon, J.-L., Góméz, E., Géret, F., & Courant, F. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-21815-5 · Cited by 8
Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury
Roth, R. A., Kana, O. Z., Filipovic, D., & Ganey, P. E. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2113379 · Cited by 9
Formation of a Toxic Quinoneimine Metabolite from Diclofenac: A Quantum Chemical Study
Ramesh, M., & Bharatam, P. V. (2018) · Drug Metabolism Letters · doi:10.2174/1872312812666180913120736 · Cited by 8
Impacts of diphenylamine NSAID halogenation on bioactivation risks
Schleiff, M. A., Payakachat, S., Schleiff, B. M., Swamidass, S. J., Boysen, G., & Miller, G. P. (2021) · Toxicology · doi:10.1016/j.tox.2021.152832 · Cited by 8
Role of Oxidative Stress and Reactive Metabolites in Cytotoxicity & Mitotoxicity of Clozapine, Diclofenac and Nifedipine in CHO-K1 Cells In Vitro
Ergüç, A., Karakuş, F., Arzuk, E., Mutlu, N., & Orhan, H. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230419084613 · Cited by 8
Bioprinting: An Industrial Perspective
Roskos, K., Stuiver, I., Pentoney, S., & Presnell, S. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800972-7.00024-4 · Cited by 8
Analgesic Activity of 5-Acetamido-2-Hydroxy Benzoic Acid Derivatives and an In-Vivo and In-Silico Analysis of Their Target Interactions
Santos, C. B. R., Lobato, C. C., Ota, S. S. B., Silva, R. C., Bittencourt, R. C. V. S., Freitas, J. J. D. S., Ferreira, E. F. B., Ferreira, M. B., Silva, R. C., de Lima, A. B., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16111584 · Cited by 7
Recent developments and applications of ambient mass spectrometry imaging in pharmaceutical research: an overview
Kumar, B. S. (2023) · Analytical Methods · doi:10.1039/d3ay01267k · Cited by 7
Discovery of subtle effects in a human intervention trial through multilevel modeling
Rubingh, C. M., van Erk, M. J., Wopereis, S., van Vliet, T., Verheij, E. R., Cnubben, N. H. P., van Ommen, B., van der Greef, J., Hendriks, H., & Smilde, A. K. (2010) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2010.06.003 · Cited by 7
Hybrid CO2-activated separation system for removal of diclofenac in aqueous solution
Huy, L. Q., & Shimoyama, Y. (2019) · Separation and Purification Technology · doi:10.1016/j.seppur.2019.02.029 · Cited by 7
Morphological Alteration in Mitochondria Following Diclofenac and Ibuprofen Administration
Moorthy, M., Fakurazi, S., & Ithnin, H. (2008) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2008.1901.1908 · Cited by 7
Identification of N-acyl-N-indanyl-α-phenylglycinamides as selective TRPM8 antagonists designed to mitigate the risk of adverse effects
Kobayashi, J., Hirasawa, H., Fujimori, Y., Nakanishi, O., Kamada, N., Ikeda, T., Yamamoto, A., & Kanbe, H. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115903 · Cited by 7
Design, Synthesis, and Biological Evaluation of New Ureido (Thioureido) Anthranilic Acid Isosteres: Molecular Docking, In Silico ADMET Predictions, and In Vivo Anti‐Inflammatory Activity
Harrouche, K., Boutaoui, N., Saidi, K. M., Stiti, M. Z., Khellafi, A., & Khelili, S. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500374 · Cited by 7
Novel indirect co-culture of immortalised hepatocytes with monocyte derived macrophages is characterised by pro-inflammatory cytokine networks
Padberg, F., Höper, T., Henkel, S., Driesch, D., Luch, A., & Zellmer, S. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105134 · Cited by 6
An Approach to Identifying Preclinical Biomarkers of Susceptibility to Drug-Induced Toxicity
Lin, W., & Chen, J. J. (2011) · Pharmacogenomics · doi:10.2217/pgs.10.204 · Cited by 6
Unpredictable Adverse Reactions to Herbal Products
Colalto, C. (2012) · Journal of Drug Metabolism & Toxicology · doi:10.4172/2157-7609.1000e105 · Cited by 6
Renoprotective and Antioxidant Effects of Silymarin and Propolis on Diclofenac Sodium - Induced Renal Toxicity in Rats
Amin, K. A. (2017) · International Journal of Pure & Applied Bioscience · doi:10.18782/2320-7051.2421 · Cited by 6
Computer-Aided Xenobiotic Toxicity Prediction Taking into Account their Metabolism in the Human Body
Rudik, A. V., Dmitriev, A. V., Lagunin, A. A., Ivanov, S. M., Filimonov, D. A., & Poroikov, V. (2019) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750819030065 · Cited by 6
Attenuated gastropathy but not enteropathy of diclofenac–cholestyramine complex in rats
Ramírez‐Alcántara, V., Castañeda‐Hernández, G., Rampy, B. A., Aronson, J. F., & Treinen–Moslen, M. (2005) · Drug Development Research · doi:10.1002/ddr.10417 · Cited by 6
Bioactivation by Phase‐ II ‐Enzyme‐Catalyzed Conjugation of Xenobiotics
Grillo, M. P. (2012) · Encyclopedia of Drug Metabolism and Interactions · doi:10.1002/9780470921920.edm074 · Cited by 6
Lumiracoxib metabolism in male C57bl/6J mice: characterisation of novelin vivometabolites
Dickie, A. P., Wilson, C. E., Schreiter, K., Wehr, R., Wilson, I. D., & Riley, R. J. (2016) · Xenobiotica · doi:10.1080/00498254.2016.1206239 · Cited by 5
Role of Toxicogenomics in the Development of Safe, Efficacious and Novel Anti-microbial Therapies.
Sabir, J. S. M., Abuzinadah, O. A., Bora, R. S., Ahmed, M. M. M., & Saini, K. S. (2013) · Infectious Disorders - Drug Targets · doi:10.2174/1871526511313030009 · Cited by 5
Effects of Adjuvant-Induced Inflammation on Disposition of Diclofenac and Its Metabolites in Perfused Rat Liver
Uraki, M., Kawase, A., Sayama, H., Matsushima, Y., & Iwaki, M. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.12.021 · Cited by 5
Human superoxide dismutase 1 attenuates quinoneimine metabolite formation from mefenamic acid
Ogiso, T., Fukami, T., Zhongzhe, C., Konishi, K., Nakano, M., & Nakajima, M. (2020) · Toxicology · doi:10.1016/j.tox.2020.152648 · Cited by 5
HPLC–MS Profiling and Structural Identification of [14C]-Diclofenac Metabolites in Mouse Bile
Sarda, S., Partridge, E. A., Pickup, K., McCarthy, A., & Wilson, I. D. (2013) · Chromatographia · doi:10.1007/s10337-013-2594-4 · Cited by 5
Humane Enzyme für die organische Synthese
Winkler, M., Geier, M., Hanlon, S. P., Nidetzky, B., & Glieder, A. (2018) · Angewandte Chemie · doi:10.1002/ange.201800678 · Cited by 5

Authors: Boelsterli, U.
Affiliations: University of Basel (CH)
Corresponding author: Boelsterli, U
Venue: Toxicology and Applied Pharmacology
Publisher: Elsevier BV
Published: 2003-11-01
Volume: 192
Issue: 3
Pages: 307-322
ISSN: 0041-008X (ISSN-L)
DOI: 10.1016/s0041-008x(03)00368-5
OpenAlex: W2003181581
Cited by: 403
References: 101
Citations by year: 2026: 11 · 2025: 10 · 2024: 8 · 2023: 17 · 2022: 12 · 2021: 20 · 2020: 17 · 2019: 18 · 2018: 15 · 2017: 23 · 2016: 30 · 2015: 17 · 2014: 17 · 2013: 20 · 2012: 20
FWCI: 8.24
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Toxicology and Applied Pharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords: diclofenac, hepatotoxicity, idiosyncratic drug toxicity, nonsteroidal anti-inflammatory drugs, CYP2C9, CYP3A4, UGT2B7, quinone imines, acyl glucuronides, MRP2, bile transport, oxidative stress, mitochondrial injury, mitochondrial permeability transition pore, immune-mediated liver injury, T cell sensitization, osteoarthritis, toxicodynamics
MeSH terms: Animals, Anti-Inflammatory Agents, Non-Steroidal, Diclofenac, Humans, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks